On May 3, 2008, a National Cancer Institute (NCI)-sponsored open consensus conference was held in Toronto, Ontario, Canada, during the 2008 International Society for Magnetic Resonance in Medicine Meeting. Approximately 100 experts and stakeholders summarized the current understanding of diffusion-weighted magnetic resonance imaging (DW-MRI) and reached consensus on the use of DW-MRI as a cancer imaging biomarker. DW-MRI should be tested as an imaging biomarker in the context of well-defined clinical trials, by adding DW-MRI to existing NCI-sponsored trials, particularly those with tissue sampling or survival indicators. Where possible, DW-MRI measurements should be compared with histologic indices including cellularity and tissue response. There is a need for tissue equivalent diffusivity phantoms; meanwhile, simple fluid-filled phantoms should be used. Monoexponential assessments of apparent diffusion coefficient values should use two b values (>100 and between 500 and 1000 mm2/sec depending on the application). Free breathing with multiple acquisitions is superior to complex gating techniques. Baseline patient reproducibility studies should be part of study designs. Both region of interest and histogram analysis of apparent diffusion coefficient measurements should be obtained. Standards for measurement, analysis, and display are needed. Annotated data from validation studies (along with outcome measures) should be made publicly available. Magnetic resonance imaging vendors should be engaged in this process. The NCI should establish a task force of experts (physicists, radiologists, and oncologists) to plan, organize technical aspects, and conduct pilot trials. The American College of Radiology Imaging Network infrastructure may be suitable for these purposes. There is an extraordinary opportunity for DW-MRI to evolve into a clinically valuable imaging tool, potentially important for drug development.

Genetic studies aimed at understanding the molecular basis of complex human phenotypes require the genotyping of many thousands of single-nucleotide polymorphisms (SNPs) across large numbers of individuals. Public efforts have so far identified over two million common human SNPs; however, the scoring of these SNPs is labor-intensive and requires a substantial amount of automation. Here we describe a simple but effective approach, termed whole-genome sampling analysis (WGSA), for genotyping thousands of SNPs simultaneously in a complex DNA sample without locus-specific primers or automation. Our method amplifies highly reproducible fractions of the genome across multiple DNA samples and calls genotypes at >99% accuracy. We rapidly genotyped 14,548 SNPs in three different human populations and identified a subset of them with significant allele frequency differences between groups. We also determined the ancestral allele for 8,386 SNPs by genotyping chimpanzee and gorilla DNA. WGSA is highly scaleable and enables the creation of ultrahigh density SNP maps for use in genetic studies.

We present a genotyping method for simultaneously scoring 116,204 SNPs using oligonucleotide arrays. At call rates >99%, reproducibility is >99.97% and accuracy, as measured by inheritance in trios and concordance with the HapMap Project, is >99.7%. Average intermarker distance is 23.6 kb, and 92% of the genome is within 100 kb of a SNP marker. Average heterozygosity is 0.30, with 105,511 SNPs having minor allele frequencies >5%.

This functional magnetic resonance imaging study investigated the impact of early auditory deprivation and/or use of a visuospatial language [American sign language (ASL)] on the organization of neural systems important in visual motion processing by comparing hearing controls with deaf and hearing native signers. Participants monitored moving flowfields under different conditions of spatial and featural attention. Recruitment of the motion-selective area MT-MST in hearing controls was observed to be greater when attention was directed centrally and when the task was to detect motion features, confirming previous reports that the motion network is selectively modulated by different aspects of attention. More importantly, we observed marked differences in the recruitment of motion-related areas as a function of early experience. First, the lateralization of MT-MST was found to shift toward the left hemisphere in early signers, suggesting that early exposure to ASL leads to a greater reliance on the left MT-MST. Second, whereas the two hearing populations displayed more MT-MST activation under central than peripheral attention, the opposite pattern was observed in deaf signers, indicating enhanced recruitment of MT-MST during peripheral attention after early deafness. Third, deaf signers, but neither of the hearing populations, displayed increased activation of the posterior parietal cortex, supporting the view that parietal functions are modified after early auditory deprivation. Finally, only in deaf signers did attention to motion result in enhanced recruitment of the posterior superior temporal sulcus, establishing for the first time in humans that this polymodal area is modified after early sensory deprivation. Together these results highlight the functional and regional specificity of neuroplasticity in humans.